- CEP-37440
-
- $1.00 / 1KG
-
2020-01-01
- CAS: 1391712-60-9
- Min. Order: 1KG
- Purity: 95-99%
- Supply Ability: 1ton
|
| | CEP-37440 Basic information |
| Product Name: | CEP-37440 | | Synonyms: | CEP-37440;2-[[5-Chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methylbenzamide;2-(5-chloro-2-{(S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino}pyrimidin-4-ylamino)-N-methylbenzamide;(S)-2-((5-chloro-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide;CEP37440;CEP 37440;CS-1603;Benzamide, 2-[[5-chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methyl-;inhibit,Inhibitor,Cluster of differentiation 246,PTK2,triple-negative breast cancer,inflammatory breast cancer,CEP-37440,Anaplastic lymphoma kinase,FAK1,Anaplastic lymphoma kinase (ALK),Focal adhesion kinase,CEP 37440,PTK2 protein tyrosine kinase 2,autophosphorylation kinase,CD246,FAK,ALK tyrosine kinase receptor | | CAS: | 1391712-60-9 | | MF: | C30H38ClN7O3 | | MW: | 580.12 | | EINECS: | 200-258-5 | | Product Categories: | Inhibitors | | Mol File: | 1391712-60-9.mol |  |
| | CEP-37440 Chemical Properties |
| density | 1.300±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C(protect from light) | | solubility | DMF: 12 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.3 mg/ml | | form | A crystalline solid | | pka | 14.57±0.46(Predicted) |
| | CEP-37440 Usage And Synthesis |
| Uses | CEP-37440 is a highly potent, selective and orally active inhibitor of ALK. |
| | CEP-37440 Preparation Products And Raw materials |
|